PAP
MIRM icon

Persistent Asset Partners’s Mirum Pharmaceuticals MIRM Stock Holding History

Persistent Asset Partners’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$516K Buy
4,404
+824
+23% +$82.7K 0.15% 110
2026
Q1 		$331K Sell
3,580
-6,609
-65% -$622K 0.12% 143
2025
Q4 		$805K Buy
+10,189
New +$731K 0.36% 76

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Persistent Asset Partners's MIRM Position: Q2 2026 in Review

Persistent Asset Partners increased its Mirum Pharmaceuticals (MIRM) stake by 23% in Q2 2026, buying an estimated $82.7K and bringing the position to 4,404 shares worth $516K. The position accounts for 0.15% of the portfolio, ranked #110.

Persistent Asset Partners first reported a position in MIRM in Q4 2025 and has held it in 3 quarters since. The position peaked at $805K in Q4 2025. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Persistent Asset Partners held 4,404 shares of Mirum Pharmaceuticals worth $516K as of Q2 2026.
  • Persistent Asset Partners bought 824 Mirum Pharmaceuticals shares in Q2 2026, an estimated $82.7K.
  • Mirum Pharmaceuticals made up 0.15% of Persistent Asset Partners's portfolio in Q2 2026, its #110 holding.
  • Persistent Asset Partners first reported a position in Mirum Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Persistent Asset Partners's Mirum Pharmaceuticals position peaked at $805K in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.